Correct Answer: A. Low TSH levels
Grave's disease is an autoimmune thyroiditis where thyroid-stimulating immunoglobulins (TSI) bind to TSH receptors on thyroid follicular cells, causing unregulated thyroid hormone synthesis and release. This leads to primary hyperthyroidism. In primary hyperthyroidism, the elevated circulating free T4 and T3 exert strong negative feedback on the anterior pituitary, suppressing thyrotropin-releasing hormone (TRH) and TSH secretion. Therefore, TSH levels are characteristically low or suppressed (typically <0.1 mIU/L, often undetectable). This is the hallmark finding in Grave's disease and distinguishes it from secondary or tertiary hyperthyroidism (where TSH would be elevated). The clinical presentation—tremors, palpitations, weight loss, and menstrual irregularities—reflects the hypermetabolic state and sympathomimetic effects of excess thyroid hormone. TSH suppression is the most sensitive and earliest indicator of primary hyperthyroidism and is used to confirm the diagnosis and monitor treatment response in Indian clinical practice, as per Harrison and standard endocrinology protocols.
Why the other options are wrong
B. Radioactive iodine uptake (RAIU) at 24 hours below normal — This is incorrect because Grave's disease is characterized by increased RAIU (typically >30–50% at 24 hours, normal <15%), reflecting the hyperactive thyroid gland's avid uptake of iodine for hormone synthesis. Low RAIU is seen in thyroiditis (silent, postpartum, De Quervain's) or iodine-induced hyperthyroidism (Jod-Basedow), not Grave's. This option confuses the pathophysiology of different causes of hyperthyroidism. C. Low free T4 levels — This is incorrect because Grave's disease causes elevated free T4 (and free T3), not low levels. The TSI-driven thyroid overproduction results in high circulating thyroid hormones, which is why patients present with hypermetabolic symptoms. Low free T4 would indicate hypothyroidism or inadequate thyroid hormone replacement, not active Grave's disease. This is a common trap for students confusing hyperthyroidism with hypothyroidism. D. Low serum T3 levels — This is incorrect because Grave's disease causes elevated serum T3 (and T4). In fact, T3 levels are often disproportionately elevated relative to T4 in Grave's disease, a phenomenon called T3 thyrotoxicosis, where the thyroid preferentially secretes T3. Low T3 is seen in hypothyroidism, sick euthyroid syndrome, or iodine deficiency, not in active Grave's disease. This option reverses the expected biochemical pattern.
High-Yield Facts
- TSH suppression (<0.1 mIU/L) is the hallmark of primary hyperthyroidism in Grave's disease due to negative feedback from elevated free T4 and T3.
- RAIU is elevated (>30–50% at 24 hours) in Grave's disease; low RAIU indicates thyroiditis or iodine-induced hyperthyroidism.
- Free T4 and free T3 are both elevated in Grave's disease; T3 may be disproportionately high (T3 thyrotoxicosis).
- TSI (thyroid-stimulating immunoglobulins) are pathognomonic for Grave's disease and distinguish it from other causes of hyperthyroidism.
- TSH-receptor antibodies drive continuous thyroid stimulation in Grave's disease, unlike transient thyroiditis.
Mnemonics
PRIMARY vs SECONDARY Hyperthyroidism PRIMARY (Grave's, Toxic nodule, Thyroiditis): High T4/T3, LOW TSH (pituitary feedback suppressed). SECONDARY (TSH-secreting pituitary adenoma): High T4/T3, HIGH TSH (pituitary drives thyroid). Use: Whenever you see hyperthyroidism, check TSH direction to localize the lesion. RAIU in Hyperthyroidism causes HIGH RAIU: Grave's, Toxic nodule, Thyroiditis (early). LOW RAIU: Thyroiditis (late), Iodine-induced (Jod-Basedow), Exogenous thyroid hormone. Use: RAIU differentiates Grave's (high) from thyroiditis (low) when TSH is suppressed in both.
NBE Trap
NBE pairs "hyperthyroidism" with "low thyroid hormones" to trap students who confuse the direction of thyroid hormone changes. Students may also conflate Grave's disease with thyroiditis (which also suppresses TSH but has low RAIU), leading to selection of option B.
Clinical Pearl
In Indian clinical practice, TSH suppression is the first biochemical clue to hyperthyroidism and guides antithyroid drug initiation (PTU or methimazole). A normal or elevated TSH in a symptomatic patient should prompt investigation for secondary hyperthyroidism or factitious thyrotoxicosis—rare but important in the differential.
_Reference: Harrison Ch. 405 (Thyroid Disorders); Robbins Ch. 24 (Endocrine Pathology); KD Tripathi Ch. 33 (Thyroid Hormones)_